Yahoo Finance Results
The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial ResultsBenzinga via Yahoo FinanceSep 05 12:28 PM
NASDAQ: GHDX) Haemonetics Corporation (NYSE: HAE) Inspire Medical Systems Inc (NYSE: INSP) Masimo Corporation (NASDAQ: MASI) Myriad Genetics, Inc. NASDAQ: MYGN) Neurocrine Biosciences, Inc.
Global Moyamoya Market Report 2018 : Data Includes Research & Development News, Patient Uprising Explored Through 2018-2023Market Watch2 hours ago
- Market Watch7 days ago
- Market Watch3 days ago
- Zacks via Yahoo FinanceSep 07 14:41 PM
Novartis to Sell Parts of Sandoz for $1 Billion: Novartis said it will sell selected portions of the Sandoz US portfolio, comprising approximately 300 products, to Aurobindo Pharma USA Inc., ...
- Other OTC
- Zacks via Yahoo FinanceSep 10 12:04 PM
Chicago, IL –September 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting ...
Stock analysis for Eisai Co Ltd (4523:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Eisai Co. Ltd. stock price, stock quotes and financial overviews from MarketWatch.
Updated key statistics for Eisai Co. Ltd. - including esalf margins, P/E ratio, valuation, profitability, company description, and other stock analysis data.
The following slide deck was published by Eisai Co., Ltd. ADR in conjunction with their 2018 Q1 earnings call.
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as “giving ...
- related to EISAI, Co., Ltd